The STOP-MED CTRCD Trial
Conditions: Heart Failure; Cardiotoxicity; Cardiac Toxicity; Antineoplastics Toxicity; Cancer Interventions: Other: Stopping Heart Failure Medication(s) Sponsors: University Health Network, Toronto; Unity Health Toronto; Hamilton Health Sciences Corporation; St. Boniface Hospital; University of Alberta; University of Ottawa Heart Institute, Canada; University College London Hospitals; Alberta Health Services, Calgary; Brigham and Women ' s Hospital; Baker Heart and Diabetes Institute Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Canada Health | Cancer | Cancer & Oncology | Cardiology | Diabetes | Endocrinology | Heart | Heart Failure | Hospitals | Research | Toxicology | University of Ottawa | Women